CN106418553A - 一种乳丙种球蛋白免疫胶囊及其制备方法 - Google Patents
一种乳丙种球蛋白免疫胶囊及其制备方法 Download PDFInfo
- Publication number
- CN106418553A CN106418553A CN201610840873.2A CN201610840873A CN106418553A CN 106418553 A CN106418553 A CN 106418553A CN 201610840873 A CN201610840873 A CN 201610840873A CN 106418553 A CN106418553 A CN 106418553A
- Authority
- CN
- China
- Prior art keywords
- gamma globulin
- vitamin
- capsule
- parts
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 31
- 108010074605 gamma-Globulins Proteins 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000013336 milk Nutrition 0.000 title abstract 6
- 239000008267 milk Substances 0.000 title abstract 6
- 210000004080 milk Anatomy 0.000 title abstract 6
- 230000036039 immunity Effects 0.000 claims abstract description 21
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 13
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 13
- 235000021241 α-lactalbumin Nutrition 0.000 claims abstract description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 244000068988 Glycine max Species 0.000 claims abstract description 8
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 8
- 240000008415 Lactuca sativa Species 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 8
- 235000012045 salad Nutrition 0.000 claims abstract description 8
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 8
- 239000011719 vitamin A Substances 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 229940045997 vitamin a Drugs 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 210000000481 breast Anatomy 0.000 claims description 11
- 108010010803 Gelatin Proteins 0.000 claims description 10
- 229920000159 gelatin Polymers 0.000 claims description 10
- 239000008273 gelatin Substances 0.000 claims description 10
- 235000019322 gelatine Nutrition 0.000 claims description 10
- 235000011852 gelatine desserts Nutrition 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 5
- 239000004568 cement Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 2
- 239000010687 lubricating oil Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000005453 pelletization Methods 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- 241000825107 Hierochloe Species 0.000 description 2
- 235000015466 Hierochloe odorata Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种乳丙种球蛋白免疫胶囊及其制备方法,乳丙种球蛋白免疫胶囊包括胶囊外壳以及内容物,内容物包括以下重量份的原料:乳丙种球蛋白 30‑60;α‑乳白蛋白10‑30;维生素C 20‑40;维生素A 0.5‑2;绞股蓝2‑5;炙甘草粉 1‑5;大豆色拉油70‑120。本发明产品整洁美观,容易吞服,色泽均匀,无明显气泡,且添加了天然活性成分,对提高免疫力十分有效。
Description
技术领域
本发明涉及一种乳丙种球蛋白免疫胶囊及其制备方法,属于药品及保健品领域。
背景技术
免疫力是人体自身的防御机制,是人体识别和消灭外来侵入的任何异物(病毒、细菌等),处理衰老、损伤、死亡、变性的自身细胞以及识别和处理体内突变细胞和病毒感染细胞的能力。现代免疫学认为,免疫力是人体识别和排除“异己”的生理反应。人体内执行这一功能的是免疫***。
免疫力低下的身体易于被感染或患癌症;免疫力超常也会产生对身体有害的结果,如引发过敏反应、自身免疫疾病等。
各种原因使免疫***不能正常发挥保护作用,在此情况下,极易招致细菌、病毒、真菌等感染,因此免疫力低下最直接的表现就是容易生病。因经常患病,加重了机体的消耗,所以一般有体质虚弱、营养不良、精神萎靡、疲乏无力、食欲降低、睡眠障碍等表现,生病、***吃药便成了家常便饭。每次生病都要很长时间才能恢复,而且常常反复发作。长此以往会导致身体和智力发育不良,还易诱发重大疾病。
丙种球蛋白含有健康人群血清所具有的各种抗体,与细菌、病毒和毒素结合,使之丧失致病功能,对炎症、肿瘤等有治疗、抑制作用,因而有增强机体抵抗力以预防感染的作用。
α-乳白蛋白是必需氨基酸和支链氨基酸的极好来源,也是唯一能与金属元素和钙元素结合的乳清蛋白成分。最近的研究更发现,它可能具有抗癌功能。此外乳白蛋白在氨基酸比例结构方面,以及在功能特性上与人乳都非常相似的。能提高免疫力,减少疾病发生。更好消化吸收,减轻肾脏负担。促进钙吸收,提升补钙效果。含有丰富色氨酸(快乐因子),睡眠、情绪更好,增进食欲。
目前还未有以丙种球蛋白和α-乳白蛋白作为主要原料来制备提高免疫力药物的报道。
发明内容
本发明涉及一种乳丙种球蛋白免疫胶囊及其制备方法,其能够大大提高人体的免疫力。
本发明技术方案是:
一种乳丙种球蛋白免疫胶囊,包括胶囊外壳以及内容物,所述内容物包括以下重量份的原料:
乳丙种球蛋白 30-60
α-乳白蛋白 10-30
维生素C 20-40
维生素A 0.5-2
绞股蓝 2-5
炙甘草粉 1-5
大豆色拉油 70-120
进一步优选为,所述内容物包括以下重量份的原料:
乳丙种球蛋白 30-60
α-乳白蛋白 10-30
维生素C 20-40
维生素A 0.5-2
绞股蓝 2-5
炙甘草粉 1-5
大豆色拉油 70-120
上述乳丙种球蛋白免疫胶囊的制备方法,包括以下步骤:
a) 配料:取乳丙种球蛋白、α-乳白蛋白、绞股蓝、炙甘草粉、维生素C、维生素A、大豆色拉油混合均匀得到内容物。
b)溶胶:取明胶加入适量水充分溶胀得到明胶液;将水与甘油混合,于水浴中加热至60-80℃,然后加入上述明胶液,搅拌使其混合均匀制成胶浆;其中明胶为150-200重量份,甘油为50-80重量份,明胶中加入的水和甘油中加入的水总共为150-200重量份;
c)制丸:将胶浆和内容物放入胶囊机制成胶囊;
d)洗涤:用乙醇洗去润滑油;
e)干燥:烘干,成丸。
进一步优选的,所述步骤b)中搅拌时间为1-1.5h。
进一步优选的,所述步骤d)中的乙醇为95%的乙醇。
进一步优选的,所述步骤e)中烘干温度为30-35℃。
有益效果
本发明产品整洁美观,容易吞服,色泽均匀,无明显气泡,且添加了天然活性成分,对提高免疫力十分有效。
具体实施方式
以下结合具体实施例对本发明做进一步的说明。
实施例1
将乳丙种球蛋白30kg、α-乳白蛋白15kg、 维生素C 20kg、维生素A 0.5kg、绞股蓝2kg、炙甘草粉1kg、大豆色拉油70kg搅拌均匀,脱泡,最后灌装制成胶囊,胶囊每粒500mg。
实施例2
将乳丙种球蛋白45kg、α-乳白蛋白20kg、 维生素C25kg、维生素A1kg、绞股蓝4kg、炙甘草粉3kg、大豆色拉油 80kg搅拌均匀,脱泡,最后灌装制成软胶囊,胶囊每粒500mg。
实施例3
将乳丙种球蛋白50kg、α-乳白蛋白22kg、 维生素C28kg、维生素A1kg、绞股蓝4kg、炙甘草粉3kg、大豆色拉油90kg搅拌均匀,脱泡,最后灌装制成胶囊,胶囊每粒500mg。
毒性试验
本实验采用健康 SD 大鼠 ,口服给药实施例 1-3制备的药物剂量梯度均为 0.01g/kg以及0.1g/kg,连续给药30天,经观察大鼠给药期间及停药后1周之内动物生长状态、活动饮食、血液学、血液生化学、脏器组织结构以及尿常规等均无明显影响,表明临床用药安全可靠。
试用结果:
在具体实施操作中,邀约80名经常情绪烦躁,精神焦虑,感冒反复发作,工作不起劲,经常感觉累的亚健康人群分组实验。结果见表一
组别 项目 | 例数(人) | 周期(天) | 总有效率(%) |
对照组 | 20 | 30 | 0 |
实施例1 | 20 | 30 | 90 |
实施例2 | 20 | 30 | 95 |
实施例3 | 20 | 30 | 98 |
由上表一可得,连续试吃实施例1-3免疫胶囊一个月后,相比较对照组(不吃免疫胶囊),实施例 1,2 , 3 组的总有效率显著提高。表明本发明乳丙种球蛋白免疫胶囊具有显著的提高免疫力效果。
Claims (6)
1.一种乳丙种球蛋白免疫胶囊,其特征在于,包括胶囊外壳以及内容物,所述内容物包括以下重量份的原料:
乳丙种球蛋白 30-60
α-乳白蛋白 10-30
维生素C 20-40
维生素A 0.5-2
绞股蓝 2-5
炙甘草粉 1-5
大豆色拉油 70-120。
2.根据权利要求1所述的乳丙种球蛋白免疫胶囊,其特征在于,所述内容物包括以下重量份的原料:
乳丙种球蛋白 30-60
α-乳白蛋白 10-30
维生素C 20-40
维生素A 0.5-2
绞股蓝 2-5
炙甘草粉 1-5
大豆色拉油 70-120。
3.权利要求1或2所述的乳丙种球蛋白免疫胶囊的制备方法,其特征在于,包括以下步骤:
a) 配料:取乳丙种球蛋白、α-乳白蛋白、绞股蓝、炙甘草粉、维生素C、维生素A、大豆色拉油混合均匀,真空脱泡得到内容物;
b)溶胶:取明胶加入适量水充分溶胀得到明胶液;将水与甘油混合,于水浴中加热至60-80℃,然后加入上述明胶液,搅拌使其混合均匀制成胶浆;其中明胶为150-200重量份,甘油为50-80重量份,明胶中加入的水和甘油中加入的水总共为150-200重量份;
c)制丸:将胶浆和内容物放入胶囊机制成胶囊;
d)洗涤:用乙醇洗去润滑油;
e)干燥:烘干,成丸。
4.根据权利要求3所述的乳丙种球蛋白免疫胶囊的制备方法,其特征在于,所述步骤b)中搅拌时间为1-1.5h。
5.根据权利要求3所述的乳丙种球蛋白免疫胶囊的制备方法,其特征在于,所述步骤d)中的乙醇为95%的乙醇。
6.根据权利要求3所述的乳丙种球蛋白免疫胶囊的制备方法,其特征在于,所述步骤e)中烘干温度为30-35℃。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610713655 | 2016-08-24 | ||
CN2016107136552 | 2016-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106418553A true CN106418553A (zh) | 2017-02-22 |
Family
ID=58167441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610840873.2A Pending CN106418553A (zh) | 2016-08-24 | 2016-09-22 | 一种乳丙种球蛋白免疫胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106418553A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1174742A (zh) * | 1997-08-06 | 1998-03-04 | 上海科星生物技术有限公司 | 复方牛乳丙种球蛋白及其制作方法 |
CN1545922A (zh) * | 2003-07-31 | 2004-11-17 | 余国华 | 丙种球蛋白健康食品(sars保健食品)及其制造方法 |
CN1557489A (zh) * | 2004-01-15 | 2004-12-29 | 高春平 | 从乳清中制备口服免疫球蛋白 |
CN1939537A (zh) * | 2005-09-27 | 2007-04-04 | 程国根 | 丙种免疫球蛋白胶囊的制备方法 |
CN101301078A (zh) * | 2008-05-29 | 2008-11-12 | 陈西喆 | 营养保健食品及其制备方法 |
CN102551073A (zh) * | 2012-02-22 | 2012-07-11 | 浙江康恩贝健康产品有限公司 | 一种含α-乳白蛋白和乳铁蛋白的营养组合物及其应用 |
CN103349125A (zh) * | 2013-07-22 | 2013-10-16 | 北京绿源求证科技发展有限责任公司 | 一种改善睡眠的食品养生茶冲剂 |
-
2016
- 2016-09-22 CN CN201610840873.2A patent/CN106418553A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1174742A (zh) * | 1997-08-06 | 1998-03-04 | 上海科星生物技术有限公司 | 复方牛乳丙种球蛋白及其制作方法 |
CN1545922A (zh) * | 2003-07-31 | 2004-11-17 | 余国华 | 丙种球蛋白健康食品(sars保健食品)及其制造方法 |
CN1557489A (zh) * | 2004-01-15 | 2004-12-29 | 高春平 | 从乳清中制备口服免疫球蛋白 |
CN1939537A (zh) * | 2005-09-27 | 2007-04-04 | 程国根 | 丙种免疫球蛋白胶囊的制备方法 |
CN101301078A (zh) * | 2008-05-29 | 2008-11-12 | 陈西喆 | 营养保健食品及其制备方法 |
CN102551073A (zh) * | 2012-02-22 | 2012-07-11 | 浙江康恩贝健康产品有限公司 | 一种含α-乳白蛋白和乳铁蛋白的营养组合物及其应用 |
CN103349125A (zh) * | 2013-07-22 | 2013-10-16 | 北京绿源求证科技发展有限责任公司 | 一种改善睡眠的食品养生茶冲剂 |
Non-Patent Citations (1)
Title |
---|
闫丽霞: "《药物制剂技术》", 31 August 2012, 华中科技大学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107668459A (zh) | 一种香菇小分子肽复配的固体饮料及其制备方法 | |
CN103404758A (zh) | 一种胃溃疡患者食用的特殊膳食 | |
TW201216980A (en) | Compositions and methods for treating hepatitis virus infection | |
CN101306105B (zh) | 一种防治产后缺乳的药物 | |
CN101569412B (zh) | 一种运动营养补剂及其应用 | |
US10821149B2 (en) | Composition and the use thereof | |
CN101297889B (zh) | 治疗***的中药制剂及其制备方法 | |
CN109757733A (zh) | 一种口服多肽粉及其制备方法和应用 | |
CN107348365A (zh) | 一种新型纳豆多肽保健食品 | |
CN107616402A (zh) | 一种黑米小分子肽复配的固体饮料及其制备方法 | |
CN104522572A (zh) | 一种补气益脾的葛根粉 | |
CN105663204A (zh) | 一种具有提高免疫功能、抗疲劳、治疗感冒的组合物和制剂及其制备方法和用途 | |
CN110326776A (zh) | 一种适合航天员的提高免疫力的药食同源复合制剂 | |
CN105231461A (zh) | 一种提高机体免疫力的营养组合物及其应用 | |
CN106418553A (zh) | 一种乳丙种球蛋白免疫胶囊及其制备方法 | |
CN104855969A (zh) | 肝病非全营养配方食品 | |
CN103798596B (zh) | 一种供心脑血管疾病患者食用的全营养配方食品 | |
CN109805235B (zh) | 一种辅助降四高的麦香复合多肽固体饮料、制备方法及用途 | |
CN103947816A (zh) | 富硒口香糖 | |
CN104606627B (zh) | 一种治疗仔猪腹泻的药物组合物及其制备方法 | |
WO2013009194A1 (es) | Suplemento alimenticio de alto valor inmunológico, en base a una matriz proteica | |
CN103271992B (zh) | 一种用于提高免疫力的药物组合物 | |
CN107136510A (zh) | 一种提高免疫力保健食品及其制备方法 | |
CN106723022A (zh) | 一种梅花鹿茸蝙蝠蛾拟青霉菌胶囊及其制备方法 | |
CN105943948A (zh) | 治疗缺铁性贫血的药物组合物、蜜丸及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |